ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years
Feng Luo
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- Research Progress of Neural Invasion in Pancreatic Cancer. First author DOI 10.2174/1568009623666230817105221↗
- Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells. Last author DOI 10.1093/abbs/gmz071↗
- Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer. First author DOI 10.3892/ijo.2016.3772↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jian Xu · 3 shared papers, 2017–2024 · strength 0.49
- Paper Research Progress of Neural Invasion in Pancreatic Cancer. DOI 10.2174/1568009623666230817105221↗
- Paper Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of p… DOI 10.1093/abbs/gmz071↗
- Paper Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer. DOI 10.3892/ijo.2016.3772↗
- Mengying Zhu · 1 shared paper, 2024 · strength 0.31
- Songmei Lou · 1 shared paper, 2019 · strength 0.10
- Zhifang Gui · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.